Dr. Srikala (Kala) Sridhar
(MD, MSc, FRCPC)

Dr. Srikala Sridhar is a Professor in the Department of Medicine at the University of Toronto and a Genitourinary Medical Oncologist at the Princess Margaret Cancer Center. She is Chair of the Genitourinary Medical Oncologists of Canada and Vice Chair of the Medical Advisory Board of Bladder Cancer Canada. She is also a member of the Canadian Clinical Trials Group, GU Disease Site Executive Committee and the US NCI Bladder Cancer Task Force. Her main area of interest is in new drug development and Phase II clinical trials. She has been the principal investigator or co-investigator on many practice-changing trials in genitourinary oncology. She has a particular focus on advanced urothelial cancers where she is regarded as an international expert in her field. She has recently published in the New England Journal of Medicine, JAMA Oncology and European Urology. In 2011, she received a “Postgraduate Medicine Teaching Award” and in 2020, she was awarded the “University of Toronto, Department of Medicine Robert Hyland Mentorship Award.”